C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies (Q47571875)

4 February 2018

title

C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies (English)

1 reference

4 February 2018

1 reference

Alexander Fuss

1

0 references

Robert P Carroll

object named as

Robert P Carroll

6

0 references

author name string

Christopher M Hope

2

1 reference

4 February 2018

Susan Deayton

3

1 reference

4 February 2018

Greg Donald Bennett

4

1 reference

4 February 2018

Rhonda Holdsworth

5

1 reference

4 February 2018

P Toby H Coates

7

1 reference

4 February 2018

publication date

26 February 2015

1 reference

4 February 2018

published in

Nephrology

1 reference

4 February 2018

volume

20

1 reference

4 February 2018

issue

7

1 reference

4 February 2018

page(s)

467-473

1 reference

4 February 2018

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

cites work

1 reference

ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro

21 January 2018

1 reference

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients

21 January 2018

1 reference

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

21 January 2018

1 reference

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity

21 January 2018

1 reference

Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

21 January 2018

1 reference

Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss

21 January 2018

1 reference

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies

21 January 2018

1 reference

Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation.

21 January 2018

1 reference

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

21 January 2018

1 reference

Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor

21 January 2018

1 reference

Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1.

21 January 2018

1 reference

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation

21 January 2018

1 reference

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions

21 January 2018

1 reference

Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.

21 January 2018

1 reference

Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies

21 January 2018

1 reference

Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance

21 January 2018

1 reference

Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/NEP.12441

1 reference

4 February 2018

release_sg7qfuhncnfcveftk4a73ae76e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sg7qfuhncnfcveftk4a73ae76e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 February 2018